On Demand Pharmaceuticals Inc.
Rockville, MD
- UEI
- SN3RFJHJ2GP3
- CAGE
- 7L9U1
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1450 Research Blvd #210, Rockville, MD 20850, USA
- Website
- ondemandpharma.com
- Founded
- 2016
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$2,748,157 |
| FY2025 | $0 |
| FY2024 | $19,325,000 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Fund research to the recipient in the amount of 1,927,669 on contract HR0011-16-2-0029. | Defense Advanced Research Projects Agency | $63,273,730 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Cambrex | Durham, NC | 325411 Medicinal and Botanical Manufacturing |
| Accelerated Machine Design & Engineering LLC | Rockford, IL | 333517 Machine Tool Manufacturing |
| Emergent Product Development Gaithersburg Inc. | Gaithersburg, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Bachem Americas Inc. | Torrance, CA | 325411 Medicinal and Botanical Manufacturing |
About the company
On Demand Pharmaceuticals Inc. is a for-profit corporate entity registered in SAM.gov since 2016, specializing in advanced pharmaceutical manufacturing and research solutions. The company focuses on innovative approaches to pharmaceutical production, with a particular emphasis on developing flexible and distributed manufacturing capabilities for critical medical compounds. Their work appears centered on creating novel manufacturing systems that can rapidly produce pharmaceutical intermediates and active pharmaceutical ingredients (APIs) with an emphasis on adaptable, point-of-care and distributed manufacturing technologies.
The company has secured significant federal contract awards, primarily from civilian agencies like the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) and the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS). Their contract portfolio includes multiple Other Transaction Agreements (OTAs) totaling approximately $38 million, focused on developing prototype distributed manufacturing networks for critical medicines. Notable contracts include a $19 million award for producing cisatracurium drug substance and a $18.9 million contract for point-of-care medicine manufacturing technologies. They have also received a $325,000 Small Business Innovation Research (SBIR) Phase I contract from NCATS for developing small manufacturing systems to produce research-grade pharmaceutical intermediates. The contracts are not predominantly set-aside, indicating the company competes broadly in federal procurement, with a strategic focus on advanced pharmaceutical manufacturing innovations.
Quick answers
Is On Demand Pharmaceuticals Inc. registered in SAM.gov?
Yes. On Demand Pharmaceuticals Inc.'s SAM.gov registration is active through August 24, 2027.
What is On Demand Pharmaceuticals Inc.'s CAGE code?
On Demand Pharmaceuticals Inc.'s CAGE code is 7L9U1, and its Unique Entity ID (UEI) is SN3RFJHJ2GP3.
How much has On Demand Pharmaceuticals Inc. received in federal contracts?
Federal contracts obligated $16,576,843 to On Demand Pharmaceuticals Inc. in fiscal years 2023 through 2027.
What is On Demand Pharmaceuticals Inc.'s most recent federal award?
On Demand Pharmaceuticals Inc.'s most recent federal contract award is Small manufacturing systems to produce research grade pharmaceutical intermediates-diversity on demand- sbir phase 1… (75N95024C00023), from National Institute on Drug Abuse (NIH), on September 24, 2024.
On GovTribe
See On Demand Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors